Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks
Introduction
Visual pathway is a preferred place of acute and chronic damage in multiple sclerosis (MS), in which the retina and the optic nerve fibers devoid of myelin are an easily accessible model for the study, among others, of MS pathogenesis [1].
Inflammation and neurodegeneration are the two main different MS pathological processes that develop in different proportions from the beginning of the disease [2] and, although immune-regulatory and neuroprotective mechanisms may be activated from a relatively early onset of the clinical relapses [3], the course of the disease leads to an irreversible neuro-axonal loss, which is the principal cause of disability [4]. Neurodegeneration is considered a chronic, diffuse, silent, ongoing process that spreads all over the central nervous system (CNS) [2]. Sensitive accessible imaging biomarkers validation that assess objectively neurodegeneration is a priority goal in daily clinical assessment and research trials, with a potential capacity in diagnosis and monitoring MS patients [5].
Optical coherence tomography (OCT) has emerged as a safe, non-invasive, rapid imaging technique that permits obtaining cross-sectional images of the retina and the optic nerve, from which quantitative and qualitative reliable data are analyzed with a reasonable cost. Its excellent reproducibility, well correlation with clinical and paraclinical measures of disease activity and progression [6,7], and therapeutic efficacy [8], makes this ophthalmological tool an ideal complement to magnetic resonance imaging (MRI) in MS practice.
The aim of this study is to evaluate OCT correlations (macular layers and optic nerve sectors) with CNS MRI parameters according to the history of optic neuritis (HON) in different MS disease subtypes, with the hypothesis that the visual pathway is a good marker of neurodegeneration and inflammation beyond anatomical landmarks.
Section snippets
Study design
This is an observational cross-sectional study carried out by the Neurology and Ophthalmology departments of La Fe University and Polytechnic Hospital (Valencia, Spain) from October 2017 to May 2019 after the approval of the research ethics committee of our institution.
Study population and clinical assessment
Out of the 160 MS volunteers who signed written informed consent, 92 met the inclusion criteria (age over 18 years and MS diagnosed following the 2010 revised McDonald criteria [9]) and none of them met the exclusion criteria
Influence of HON in clinical, ophthalmological and neurological characteristics
Flow of participants through the study is represented in Supplementary file 3. The final cohort is characterized clinically and neuroradiologically (Table 1) as well as ophthalmologically (Table 2). Table 3, Table 4 present the aforementioned characteristics dividing the sample according to the HON for its comparison.
According to the HON, no statistically significant demographic or clinical differences are observed. In eyes with HON average pRNFL and its sectors, GCL and IPL are significantly
Discussion
There is a growing interest of studies addressing OCT measures (thicknesses or volumes) with CNS structures, mainly those involved in visual processing. That is why RNFL has been related with thalamus [18,19], visual cortex [18,[20], [21], [22]], WM lesion [20,23], and fractional anisotropy [24] of optic radiation; GCL (alone or combined with IPL) with thalamus [19,25], visual cortex [21,22], and fractional anisotropy of optic radiation [24]; INL with thalamus [19,25]; ONL with thalamus [19];
Funding
Bonaventura Casanova was supported by a fellowship from Health Institute Carlos III, Spain (FIS 17/551). The funding agency had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.
Declaration of Competing Interest
Francisco Pérez-Miralles has received compensation for serving on scientific advisory boards or for speaking honoraria from Almirall, Biogen Idec, Genzyme, Merk-Serono, Mylan, Novartis, Roche, Sanofi-Aventis and Teva, outside the submitted work. Bonaventura Casanova has received compensation from Novartis, Roche, Biogen, Merk, Teva and Sanofi outside the submitted work. All other authors have no conflicts of interest to declare.
Acknowledgements
We are extremely grateful to the multiple sclerosis participants without whose contribution this study would not be possible.
References (57)
- et al.
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
Lancet Neurol.
(2016) - et al.
Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis
J. Neurol. Sci.
(2008) - et al.
Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study
J. Neurol. Sci.
(2009) - et al.
Overlapping neural circuits for visual attention and eye movements in the human cerebellum
Neuropsychologia
(2015) The cerebellum and cognition
Neurosci. Lett.
(2019)- et al.
Longitudinal study of retinal nerve fiber layer thickness changes in a multiple sclerosis patients cohort: a long term 5 year follow-up
Mult. Scler. Relat. Disord.
(2018) - et al.
Mycrocystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study
Lancet Neurol.
(2012) - et al.
The visual pathway as a model to understand brain damage in multiple sclerosis
Mult. Scler. J.
(2014) - et al.
Neurodegeneration in multiple sclerosis and neuromyelitis optica
J. Neurol. Neurosurg. Psychiatry
(2017) - et al.
Neuroprotective and anti-inflammatory mechanisms are activated early in optic neuritis
Acta Neurol. Scand.
(2015)
Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis
Mult. Scler.
Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis
Acta Neurol. Scand.
Optical coherence tomography in acute optic neuritis: a population-based study
Acta Neurol. Scand.
Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: a retrospective study
Neurology
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Ann. Neurol.
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS
BMC Res. Notes
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
Neurology
Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial
Ophthalmology
The OSCAR-IB consensus criteria for retinal OCT quality assessment
PLoS One
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
Mult. Scler.
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies
Neurology
An effect size primer: a guide for clinicians and researchers
Prof. Psychol. Res. Pr.
The Essential Guide to Effect Sizes: Statistical Power, Meta-analysis and the Interpretation of Research Results
Retinal degeneration in primary-progressive multiple sclerosis: a role for cortical lesions?
Mult. Scler. J.
Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study
Ann. Neurol.
Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis
Ann. Neurol.
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients
Mult. Scler. J.
Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing–remitting MS
Brain Behav.
Cited by (5)
Individual differences in visual evoked potential latency are associated with variance in brain tissue volume in people with multiple sclerosis: An analysis of brain function-structure correlates
2022, Multiple Sclerosis and Related DisordersCitation Excerpt :There is some prior evidence that measures of visual pathway functioning such as VEPs may be useful along these lines. Optical Coherence Tomography (OCT) measures, which provide assessment of structural integrity of the retina and optic nerve, have been shown to correlate with whole-brain measures of atrophy (Barreiro- González et al., 2020), and broadly with measures of cognitive performance in MS (Jakimovski et al., 2021). OCT measures and damage in the optic radiations are also correlated with delays in VEPs (Berman et al., 2020; Sinnecker et al., 2015).
Combination among VEP, OCT and TCD data in patients with relapsing-remitting multiple sclerosis during attack-free period
2023, International Journal of NeuroscienceRetinal imaging with optical coherence tomography in multiple sclerosis: novel aspects
2022, Wiener Medizinische WochenschriftAssociations of optical coherence tomography with disability and brain MRI volumetry in patients with multiple sclerosis
2022, Neurologia i Neurochirurgia Polska